VK2809 found that those on the medicine saw statistically significant reductions in liver fat, meeting the primary endpoint.

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Stress hormones, not impaired insulin signaling, may underlie obesity-related diabetes, according to Rutgers research.

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-β) Agonist, was Well-tolerated with Significant Reductions in ...

A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings ...

Biohacker Bryan Johnson, 47, shared a 4-day menu featuring dishes like chickpea veggie frittata and lentil soup, sparking ...

A new study reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during their ...

High estrogen can cause a range of symptoms, including weight gain, fatigue, heavy periods, breast tenderness, and ...

Hypertension, often dubbed the "silent killer," poses a significant risk factor for stroke. The condition, often asymptomatic ...

No matter your preference, we’ve rounded up 80 of the most delicious Christmas dinner options. Here you’ll find sides, snacks ...

Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver ...

With a biology-first approach and AI-driven innovation, BPGbio is leading the charge in the AI biotech field, accelerating drug discovery and development, reducing costs, and paving the way for more ...